ACCELERATING TRANSLATION OF A SMALL-MOLECULE KCC2 ENHANCER TO PROMOTE RECOVERY AND REDUCE NEUROPATHIC PAIN AFTER SCI USING A PIG MODEL

Axonis Therapeutics, Inc., Boston MA

Investigators